CD33 and Alzheimer disease: CD33 expression was reported to inhibit uptake and clearance of Aβ1–42 in microglial cell cultures and microglia immunoreactive for CD33 were shown to correlate with insoluble Aβ levels and plaque burden in the AD brain (Griciuc et al., 2013).